Significant associations of the rs2943634 (2q36.3) genetic polymorphism with adiponectin, high density lipoprotein cholesterol and ischemic stroke

Gene

Volumn 494, Issue 2, 2012, Pages 190-195

  Arregui, Maria ^a   Fisher, Eva ^a,b   Knüppel, Sven ^a   Buijsse, Brian ^a   di Giuseppe, Romina ^a   Fritsche, Andreas ^c   Corella, Dolores ^d   Willich, Stefan N ^e   Boeing, Heiner ^a   Weikert, Cornelia ^a,e  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF VALENCIA   (Spain)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cardiovascular diseases; Risk factor; SNP

Indexed keywords

ADIPONECTIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BRAIN ISCHEMIA; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GERMANY; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STROKE;

EID: 84856328592     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.12.009     Document Type: Article

References (39)

1. Altinova A.E., et al. Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects. Endocr. J. 2007, 54:221-226.
2. Boeing H., Korfmann A., Bergmann M.M. Recruitment procedures of EPIC-Germany. European investigation into cancer and nutrition. Ann. Nutr. Metab. 1999, 43:205-215.
3. Bressler J., Folsom A.R., Couper D.J., Volcik K.A., Boerwinkle E. Genetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study. Am. J. Epidemiol. 2010, 171:14-23.
4. Brochu-Gaudreau K., et al. Adiponectin action from head to toe. Endocrine 2010, 37:11-32.
5. Cnop M., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003, 46:459-469.
6. Cunnington M.S., et al. Novel genetic variants linked to coronary artery disease by genome-wide association are not associated with carotid artery intima-media thickness or intermediate risk phenotypes. Atherosclerosis 2009, 203:41-44.
7. Faxon D.P., et al. Atherosclerotic vascular disease conference: writing group iii: pathophysiology. Circulation 2004, 109:2617-2625.
8. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18:499-502.
9. Gauderman W.J., Morrison J.M. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies 2006, (Last accessed: August 2011). http://hydra.usc.edu/gxe.
10. Ghazouani L., et al. Association of three polymorphisms selected from a genome-wide association study with coronary heart disease in the Tunisian population. J. Thromb. Thrombolysis 2010, 29:114-118.
11. Group T.A.C.P.S. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The atbc cancer prevention study group. Ann. Epidemiol. 1994, 4:1-10.
12. Heidemann C., et al. Potentially modifiable classic risk factors and their impact on incident myocardial infarction: results from the EPIC-Potsdam study. Eur. J. Cardiovasc. Prev. Rehabil. 2007, 14:65-71.
13. Karvanen J., et al. The impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohorts. Genet. Epidemiol. 2009, 33:237-246.
14. Khalili P., et al. Total adiponectin does not predict cardiovascular events in middle-aged men in a prospective, long-term follow-up study. Diabetes Metab. 2010, 36:137-143.
15. Kulathinal S., Karvanen J., Saarela O., Kuulasmaa K. Case-cohort design in practice - experiences from the MORGAM project. Epidemiol Perspect Innov 2007, 4:15.
16. Lemaitre R.N., et al. Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke. Atherosclerosis 2009, 204:e58-e63.
17. Lin H.F., et al. Chromosome 9p21 genetic variants are associated with myocardial infarction but not with ischemic stroke in a Taiwanese population. J. Investig. Med. 2011, 59:926-930.
18. M D.E.G., et al. Tissue factor gene polymorphisms and haplotypes and the risk of ischemic vascular events: four studies and a meta-analysis. J. Thromb. Haemost. 2009, 7:1465-1471.
19. Matsumoto M., Ishikawa S., Kajii E. Association of adiponectin with cerebrovascular disease: a nested case-control study. Stroke 2008, 39:323-328.
20. Matsuura F., et al. Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver. Biochem. Biophys. Res. Commun. 2007, 358:1091-1095.
21. Muendlein A., et al. Evaluation of the association of genetic variants on the chromosomal loci 9p21.3, 6q25.1, and 2q36.3 with angiographically characterized coronary artery disease. Atherosclerosis 2009, 205:174-180.
22. Oku H., et al. Adiponectin deficiency suppresses abca1 expression and apoa-i synthesis in the liver. FEBS Lett. 2007, 581:5029-5033.
23. Prentice R.L., Self S.G. Aspects of the use of relative risk models in the design and analysis of cohort studies and prevention trials. Stat. Med. 1988, 7:275-287.
24. Rajpathak S.N., et al. Resistin, but not adiponectin and leptin, is associated with the risk of ischemic stroke among postmenopausal women: results from the women's health initiative. Stroke 2011, 42:1813-1820.
25. Samani N.J., et al. Genomewide association analysis of coronary artery disease. N. Engl. J. Med. 2007, 357:443-453.
26. Samani N.J., et al. Large scale association analysis of novel genetic loci for coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2009, 29:774-780.
27. Schulze M.B., Rimm E.B., Shai I., Rifai N., Hu F.B. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care 2004, 27:1680-1687.
28. Sie M.P., et al. Tgf-beta 1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam study. Stroke 2006, 37:2667-2671.
29. Siegerink B., Rosendaal F.R., Algra A. Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke. J. Thromb. Haemost. 2009, 7:385-390.
30. Soderberg S., et al. Leptin, but not adiponectin, predicts stroke in males. J. Intern. Med. 2004, 256:128-136.
31. Stott D.J., et al. Adipocytokines and risk of stroke in older people: a nested case-control study. Int. J. Epidemiol. 2009, 38:253-261.
32. van Hoek M., et al. Role of plasma adiponectin on the hdl-cholesterol raising effect of atorvastatin in patients with type 2 diabetes. Curr. Med. Res. Opin. 2009, 25:93-101.
33. Van Linthout S., et al. Impact of hdl on adipose tissue metabolism and adiponectin expression. Atherosclerosis 2010, 210:438-444.
34. Verges B., et al. Adiponectin is an important determinant of apoa-i catabolism. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1364-1369.
35. Wang A.Z., Li L., Zhang B., Shen G.Q., Wang Q.K. Association of snp rs17465637 on chromosome 1q41 and rs599839 on 1p13.3 with myocardial infarction in an American Caucasian population. Ann. Hum. Genet. 2011, 75:475-482.
36. Wannamethee S.G., Shaper A.G., Ebrahim S. Hdl-cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke 2000, 31:1882-1888.
37. Weikert C., et al. Joint effects of risk factors for stroke and transient ischemic attack in a German population: the EPIC Potsdam study. J. Neurol. 2007, 254:315-321.
38. Weikert C., et al. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 2008, 118:2555-2562.
39. Zietz B., et al. Adiponectin represents an independent cardiovascular risk factor predicting serum hdl-cholesterol levels in type 2 diabetes. FEBS Lett. 2003, 545:103-104.